Heart attack diagnostic market seen reaching $17.9 billion by 2030

The Business Research Company says the heart attack diagnostic market will grow from $11.54 billion in 2025 to $12.64 billion in 2026, with demand fueled by rising cardiovascular disease rates and faster testing tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Heart attack diagnostics help identify a heart attack early, classify the type and guide treatment decisions. - Faster and more accurate testing can improve outcomes for patients with cardiovascular disease. - The market's growth reflects rising demand for tools that support emergency diagnosis, monitoring and precision cardiology.

What happened: - The Business Research Company released a heart attack diagnostic market report on Aug. 10, 2026. - The report values the market at $11.54 billion in 2025 and projects $12.64 billion in 2026. - The report forecasts the market will reach $17.9 billion by 2030. - The company says the market will grow at a 9.5% CAGR from 2025 to 2026 and at a 9.1% CAGR through 2030.

The details: - The report links near-term growth to rising cardiovascular disease rates, better hospital diagnostic capabilities and wider access to advanced cardiac imaging. - Improvements in laboratory testing and stronger awareness of timely heart attack detection are also listed as growth drivers. - Looking ahead, the report expects demand to rise for rapid diagnostic technologies, remote cardiac monitoring and precision cardiology diagnostics. - The report highlights trends including AI-assisted diagnostic tools, high-sensitivity cardiac biomarkers, point-of-care testing, non-invasive procedures and rapid emergency diagnostics. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report's 2026 update includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - Free sample report: Download the sample - Full report: View the report

Between the lines: - The report's growth case is driven more by clinical need and technology adoption than by any single product category. - The emphasis on AI, biomarkers and point-of-care testing points to a market shifting toward speed, portability and earlier intervention. - The regional split suggests mature demand in North America and more room for expansion in Asia-Pacific.

What's next: - The company expects continued adoption of digital health tools and remote monitoring services. - More investment in imaging modalities and broader use of non-invasive diagnostics are expected to support the market through 2030. - Market participants will likely focus on faster emergency workflows and higher-sensitivity testing as competition intensifies.

The bottom line: - Heart attack diagnostics are moving toward faster, more connected and more precise testing, and the market outlook remains strong through 2030.